Hyperinsulinemia is associated with a higher risk of breast cancer, as demonstrated in a case-cohort study by Gunter in 2015, in which the authors showed that insulin levels were positively associated with breast cancer development in postmenopausal women [129]. The gene discussed is INS; the disease is hyperinsulinism.